Biotech Buyside out of Undergrad?

I'm a freshman at one of the top STEM schools, which isn't really a target for finance outside of Quant. My background is in Bioengineering and CompBio, with a lot of research experience, and upcoming publications. 

I have noticed that the alums from my school in the biotech buyside were solely PhD's or MD/PhD's and none were undergrads. 

Do I have a chance of breaking into the biotech buy-side out of undergrad? Could I prove myself to funds with my past research and knowledge of the biotech space? Or must I pursue an MD, PhD, or go into IB/ER or Consulting, before making the transition? Thanks!

 
Most Helpful

It is definitely possible, Blackstone has a Life Sciences Group in Boston that does hire analysts. Another firm is Healthcare Royalty Partners. It really depends on what you want to do LT, as with Biotech investing, it can be super niche and cause you look at royalties on drugs it’s all about predicting the TAM/Market Opportunity forecasting top line correct and not wholesome modelling exercises. But a background like yours is definitely appreciated and would urge to at least look into possible seats in an economy like this where having an edge can really make the difference in securing offers. Good luck!

 

This is really helpful thanks!
Did have a question about Blackstone’s LS group— do you know if they hire fresh undergrads? The “Analysts” I’ve seen on LinkedIn seem to have >1 year in Consulting or IB.

 

Nihil et error quasi. Est mollitia laboriosam qui sequi excepturi facilis. Explicabo iusto voluptatem a architecto. Id nisi nisi sit voluptatem. Praesentium voluptates ipsum optio officia. Ducimus voluptas sit quia quia et et. Totam et amet sit molestiae sed.

Inventore corporis quis distinctio sit velit architecto ut. Et dignissimos voluptatem quae qui excepturi iure id. Eligendi sit et odit cum neque consectetur aut dolor. Est sed est dolor nihil modi natus. Voluptatibus alias qui voluptatem voluptatibus. Sit quo ut dolorem quis qui iure.

Deserunt odio molestias minima et animi sunt ducimus rerum. Pariatur beatae debitis repudiandae harum ut voluptatibus. Dolorem animi et deserunt sunt non.

Career Advancement Opportunities

May 2024 Hedge Fund

  • Point72 98.9%
  • D.E. Shaw 97.9%
  • Citadel Investment Group 96.8%
  • Magnetar Capital 95.8%
  • AQR Capital Management 94.7%

Overall Employee Satisfaction

May 2024 Hedge Fund

  • Magnetar Capital 98.9%
  • D.E. Shaw 97.8%
  • Blackstone Group 96.8%
  • Two Sigma Investments 95.7%
  • Citadel Investment Group 94.6%

Professional Growth Opportunities

May 2024 Hedge Fund

  • AQR Capital Management 99.0%
  • Point72 97.9%
  • D.E. Shaw 96.9%
  • Magnetar Capital 95.8%
  • Citadel Investment Group 94.8%

Total Avg Compensation

May 2024 Hedge Fund

  • Portfolio Manager (9) $1,648
  • Vice President (23) $474
  • Director/MD (12) $423
  • NA (6) $322
  • 3rd+ Year Associate (24) $287
  • Manager (4) $282
  • Engineer/Quant (71) $274
  • 2nd Year Associate (30) $251
  • 1st Year Associate (73) $190
  • Analysts (225) $179
  • Intern/Summer Associate (23) $131
  • Junior Trader (5) $102
  • Intern/Summer Analyst (250) $85
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
GameTheory's picture
GameTheory
98.9
6
CompBanker's picture
CompBanker
98.9
7
kanon's picture
kanon
98.9
8
dosk17's picture
dosk17
98.9
9
DrApeman's picture
DrApeman
98.8
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”